Thyreos

Lincoln, United States

Thyreos provides prophylactic vaccines for neuroinvasive herpesvirus infections.

$1.0M raised

Dec 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Thyreos raised?

Thyreos has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in December 2022.

Who are Thyreos's investors?

Thyreos's investors include Invest Nebraska, National Institute of Food and Agriculture.

Where is Thyreos headquartered?

Thyreos is headquartered in Lincoln, United States.

What does Thyreos do?

Thyreos provides prophylactic vaccines for neuroinvasive herpesvirus infections.

What stage is Thyreos at?

Thyreos is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2022.

MLA

"Thyreos — Funding & Investors." VCBacked, December 12, 2022, https://www.vcbacked.co/company/thyreos. Accessed July 2, 2026.

APA

VCBacked. (2022). Thyreos — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/thyreos

Wikipedia (cite web)

{{cite web |title=Thyreos — Funding & Investors |url=https://www.vcbacked.co/company/thyreos |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2022.